103,352 research outputs found
Effect of microplastics and watering regimes on a plant-soil system: Data on behavioural responses of an insect herbivore
No full textThe data presented here are related to the article titled “Microplastics alter behavioural responses of an insect herbivore to a plant-soil system” by Rondoni, G., Chierici, E., Agnelli, A., Conti, E. (2021). The data describe the changes in the attractiveness of a plant-soil system towards females of a herbivorous fungus gnat (Diptera: Sciaridae) when exposed to different combinations of the following treatments: (1) low or high plant (lentil)-soil watering regime; (2) absence (0%) or presence (5%) of HDPE microplastics in soil; (3) 1-day or 7-day duration of HDPE presence; (4) addition of fungus mycelium to the plant-soil system. We report data of female behaviour, i.e. the residence time in choice vs. no-choice sector of one-way olfactometers using a multiple olfactometer device
Pensieri filosofici / di G. B. Passerini Milano : Tip. di Pietro Agnelli, 1863
No full textPensieri filosofici / di G. B. Passerini
Milano : Tip. di Pietro Agnelli, 1863
224 p. ; 22 cm
Low molecular weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a metanalysis.
No full textRisk scores for death in patients with cancer-related venous thromboembolism. still a long road ahead
No full textPatients with cancer have an increased risk of venous thromboembolism (VTE) compared with non-cancer patients.1 In these patients, the risk of VTE is variable and seems to be related to several factors including cancer site and extension, anti-cancer treatment and several intrinsic patient characteristics.2,3 Low-molecular-weight heparin (LMWH) has been for many years the treatment of choice for cancer-related VTE. The European Society of Cardiology (ESC) guidelines published in 2019 opened to the use of direct oral anticoagulants (DOACs) for treatment of cancerrelated VTE.
Ten questions on venous thromboembolism
No full textVenous thromboembolism (VTE), which includes pulmonary embolism and deep vein thrombosis, is a leading cause of morbidity and mortality worldwide. Based on new evidence, the management and treatment of VTE have changed over the years. For several decades, low molecular weight heparin and vitamin K antagonists have been the two cornerstones of anticoagulant therapy for VTE. Recently, the introduction in clinical practice of the new oral anticoagulants has radically changed the management of VTE for their easy use and their better efficacy and safety profile. Here, we report on recent evidence of 10 still controversial clinical questions concerning common diagnostic and therapeutic aspects of VTE
Caratteristiche della carne di agnelli alimentati con insilato di residuo fibroso di topinambur (Heliantus tuberosus)
No full textSono stati effettuati alcuni esami sul muscolo Longissimus dorsi allo scopo di valutare la qualità della carne di agnelli sottoposti a dieta contenente insilato di residuo fibroso di Topinambur. I risultati delle analisi hanno mostrato che le caratteristiche del muscolo di questi soggetti erano simili a quelle riscontrate negli agnelli di controllo
Solutions to reduce cardiovascular events in patients with atrial fibrillation
No full textAF is the most common sustained cardiac rhythm disorder and an established risk factor for ischemic stroke. Ischemic strokes which occur in patients with AF are particularly severe and disabling. In addition, stroke recurrence is more common in patients with AF compared with those without it. Previous cerebrovascular events, age, hypertension, diabetes, and heart failure are risk factors for stroke in patients with AF.
Various risk stratification schemes have been developed to quantify the risk for stroke in patients with AF. Currently, the most frequently used schemes to assess stroke risk in patients with AF are CHADS2, the ACC/AHA/ESC and American College of Chest Physicians (ACCP) schemes.
Current risk scores are largely derived from risk factors identified from clinical trials and many potential risk factors have not been properly considered. Consequently, the stroke risk in many patients could be underestimated, and these patients could receive a suboptimal antithrombotic prophylaxis.
There is substantial evidence for the benefit of vitamin K antagonists (VKA) in preventing stroke and reducing mortality. Novel oral anticoagulants are available for stroke prevention in patients with AF which overcome some of the difficulties associated with VKA. The introduction of novel oral anticoagulants in clinical practice and the advances in identifying patients at risk of stroke together may overcome many of the difficulties in providing effective stroke prevention for patients with AF.AF is the most common sustained cardiac rhythm disorder and an established risk factor for ischemic stroke. Ischemic strokes which occur in patients with AF are particularly severe and disabling. In addition, stroke recurrence is more common in patients with AF compared with those without it. Previous cerebrovascular events, age, hypertension, diabetes, and heart failure are risk factors for stroke in patients with AF. Various risk stratification schemes have been developed to quantify the risk for stroke in patients with AF. Currently, the most frequently used schemes to assess stroke risk in patients with AF are CHADS2, the ACC/AHA/ESC and American College of Chest Physicians (ACCP) schemes. Current risk scores are largely derived from risk factors identified from clinical trials and many potential risk factors have not been properly considered. Consequently, the stroke risk in many patients could be underestimated, and these patients could receive a suboptimal antithrombotic prophyl..
Innovative and sustainable business in the Alpine area
No full textThe development of the Alpine Area increasingly depends on the expansion of innovative and sustainable businesses. In this scenario multifunctional agriculture and sustainable tourism and services represent the key factors to preserve natural resources and, contemporary, to increase quality of life and employment in the Alpine Area. On this point of view the expected contributions
should focus on:
a) Case studies of innovative and sustainable businesses in the Alpine areas
b) New incentive policies for SMEs in mountain areas
c) Tools to enhance integration between agriculture and tourism
d) Innovative models of BP for multifunctional enterprises, between agriculture
and tourism
e) Sustainability vs. Competitiveness for the development of mountain area
- …
